» Authors » Huanqiang Zhao

Huanqiang Zhao

Explore the profile of Huanqiang Zhao including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 222
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruan F, Wang Y, Ying X, Liu Y, Xu J, Zhao H, et al.
BMC Pregnancy Childbirth . 2025 Feb; 25(1):217. PMID: 40016711
Background: Epidemiological evidence indicates that preeclampsia (PE) is associated with comorbidities such as periodontitis (PD). However, the underlying mechanism remains unclear. To enhance our understanding of their co-pathogenesis, this research...
2.
Shao S, Xu Q, Zi Y, Zheng X, Chen S, Qin C, et al.
Eur J Obstet Gynecol Reprod Biol . 2025 Jan; 305():351-355. PMID: 39742733
Objective: In observational studies, polycystic ovary syndrome (PCOS) has been associated with an increased risk of hypertensive disorders of pregnancy (HDPs); however, the causality between these conditions remains to be...
3.
Liu L, Zhao H, Wang Y, Cui Y, Lu H, Xiong Y, et al.
Placenta . 2024 Aug; 155:100-112. PMID: 39180926
Introduction: Preeclampsia (PE), characterised by hypertension in pregnancy, is regarded as a placental metabolism-related syndrome affecting 5-8% of pregnancies worldwide. The insufficiency of polyunsaturated fatty acids (PUFAs), such as docosahexaenoic...
4.
Zhao H, Xiong Y, Zhou Z, Xu Q, Zi Y, Zheng X, et al.
Clin Transl Med . 2024 Jul; 14(7):e1759. PMID: 38997803
Background: CircRNA-encoded proteins (CEPs) are emerging as new players in health and disease, and function as baits for the common partners of their cognate linear-spliced RNA encoded proteins (LEPs). However,...
5.
Wu S, Liu K, Cui Y, Zhou B, Zhao H, Xiao X, et al.
Biochim Biophys Acta Mol Basis Dis . 2024 Jun; 1870(7):167290. PMID: 38866113
N6-methyladenosine (m6A) is the most abundant modification controlling RNA metabolism and cellular functions, but its roles in placental development are still poorly understood. Here, we characterized the synchronization of m6A...
6.
Zhao H, Wen P, Xiong Y, Xu Q, Zi Y, Zheng X, et al.
J Hypertens . 2024 May; 42(9):1606-1614. PMID: 38780189
Background: Unhealthy sleep patterns are common during pregnancy and have been associated with an increased risk of developing hypertensive disorders of pregnancy (HDPs) in observational studies. However, the causality underlying...
7.
Liu L, Zhang X, Qin K, Xu C, Ruan F, Liu Y, et al.
Obstet Gynecol Int . 2024 Feb; 2024:9070748. PMID: 38385139
Background: Altered maternal serum lipid metabolism is associated with hypertensive disorders in pregnancy (HDP). However, its range in pregnancy and characteristic among different subgroups of HDPs are unclear. Methods: Pregnant...
8.
Cui Y, Wu S, Liu K, Zhao H, Ma B, Gong L, et al.
J Reprod Immunol . 2023 Dec; 161:104186. PMID: 38134680
Introduction: Severe preeclampsia (sPE) is a systemic syndrome that may originate from chronic inflammation. Maintaining maternal-fetal hemostasis by the co-inhibitory molecule programmed death ligand 1 (PDL1) can be favorable for...
9.
Zhu J, Zhao Y, An P, Zhao Y, Li S, Zhou J, et al.
JAMA Netw Open . 2023 Nov; 6(11):e2343781. PMID: 37976061
Importance: Antenatal corticosteroid treatment of individuals with singletons at risk for delivery during the late-preterm period has been academically recommended. However, the evidence on the use of antenatal corticosteroid treatment...
10.
Zhao Z, Zhao H, Xiong Y, Zhou Q, Li X
Clin Endocrinol (Oxf) . 2023 Oct; 100(1):76-86. PMID: 37859522
Objective: Treatment indication of maternal subclinical hypothyroidism (SCH) is undetermined, despite the wide administration of levothyroxine for maternal overt hypothyroidism (OH). This study aimed to evaluate the therapeutic effect of...